Current Health Raises $11.5M in Series A Funding
Summary
Current Health, a NYC-based provider of an FDA-cleared, artificial intelligence (AI)-powered patient management platform, raised $11.5m (£9m) in Series A funding. Founded in Scotland in 2015 by CEO Christopher McCann and CTO Stewart Whiting, Current Health uses wearable and wireless vital signs monitoring, clinical indicators from an ecosystem of more than 50 integrations and symptoms collected via its patient engagement tools, to continuously track patient health trends. Leveraging proprietary machine learning algorithms, the company’s platform analyzes this data to proactively detect illness and alert providers to high-risk patients so they can deliver healthcare earlier. Today, 13 of the largest healthcare systems in the United States and United Kingdom – including Mount Sinai and Dartford & Gravesham NHS Trust – use Current Health to manage patient care. The company has secured three FDA 501(k) clearances for its platform and proven the value of its solution in some of the most demanding and respected healthcare systems in the world.